Pam Belluck is a writer covering science and medicine for the New York Times.
Segment
Read More
12:14
FDA’s Approval Of Debated Alzheimer’s Treatment Raises Controversy
The FDA approved the first drug for treatment of Alzheimer’s disease in almost 20 years. But the benefits of the costly medication aren’t clear.